- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
| Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
|---|---|---|---|---|---|---|
| Associate Director - Foundry Solution Architecture, Full Stack & AIP | Cambridge (USA) | USA | Biomedical Research | Research | Research & Development | Mar 06, 2026 |
| Associate Director, Biotherapeutic Engineering & Bioconjugation | San Diego | USA | Biomedical Research | Research | Research & Development | Mar 05, 2026 |
| Early Clinical Development Physician - Immunology | Beijing (Beijing) | China | Biomedical Research | Research | Research & Development | Mar 05, 2026 |
| Principal Scientist, Compound Hub Lab Leader, Compound Management | Cambridge (USA) | USA | Biomedical Research | Research | Research & Development | Mar 03, 2026 |
| Associate Director Biomedical Research Clinical Quality | Toranomon (NPKK Head Office) | Japan | Biomedical Research | Quality | Quality | Mar 02, 2026 |
| Recent Bachelor/Master Graduate - Stockroom team Global Discovery Chemistry | Basel (City) | Switzerland | Biomedical Research | Research | Others | Feb 26, 2026 |
| Head of Neuromuscular Diseases, Translational Medicine | San Diego | USA | Biomedical Research | Research | Research & Development | Feb 23, 2026 |
| Business Operations Lead- External Innovation | Cambridge (USA) | USA | Biomedical Research | Research | Facilities & Administration | Feb 17, 2026 |
| Senior Scientist – Small Scale Oligonucleotide Synthesis (80-100%*) | Basel (City) | Switzerland | Biomedical Research | Research | Research & Development | Feb 11, 2026 |
| Principal Scientist - Mid/Large Scale Oligonucleotide Synthesis, xRNA Therapeutics | Basel (City) | Switzerland | Biomedical Research | Research | Research & Development | Feb 11, 2026 |
| Principal Scientist, Biomarker Assay Development Bench Scientist | Cambridge (USA) | USA | Biomedical Research | Research | Research & Development | Feb 06, 2026 |
| Senior Principal Scientist/in-vivo Pharmacology Lab Head (80-100%*) | Basel (City) | Switzerland | Biomedical Research | Research | Research & Development | Jan 29, 2026 |
| Principal Scientist II | San Diego | USA | Biomedical Research | Research | Research & Development | Jan 29, 2026 |
| Director, Oncology Translational Research | Cambridge (USA) | USA | Biomedical Research | Research | Research & Development | Jan 20, 2026 |
| Director - Genetic Toxicology Expert | London (The Westworks) | United Kingdom | Biomedical Research | Research | Research & Development | Dec 10, 2025 |
| Director - Genetic Toxicology Expert | Cambridge (Massachusetts) | USA | Biomedical Research | Research | Research & Development | Dec 10, 2025 |
| Clinical Data Engineering Lead | Cambridge (USA) | USA | Biomedical Research | Research | Data and Digital | Dec 02, 2025 |
Adverse Event Reporting
We encourage using the following electronic reporting tool for reporting into the safety database directly: https://www.report.novartis.com/
If electronic reporting tool is not working – please use the following Generic mailbox: [email protected]
CISCO: +20 2 22861000: Press 3 for Adverse Event Reporting